Tirzepatide. The dual-action GLP-1.
The only GLP-1 medication that also targets GIP receptors. Clinical trials show ~20% average body weight loss — the highest of any approved weight loss medication.
From intake to your door, in days.
- Step 01Five-minute intake.
Tell us your goals, health history, and current medications.
- Step 02Clinician reviews.
A US-licensed clinician evaluates your intake and determines if tirzepatide is clinically appropriate for you.
- Step 03Delivered in 5–7 days.
Your 503A pharmacy compounds and ships your tirzepatide directly to your door.
Why tirzepatide over semaglutide?
Greater average weight loss
SURMOUNT trials showed ~20% average body weight loss vs ~15% for semaglutide. Some patients lose significantly more.
Dual mechanism
Tirzepatide targets both GLP-1 and GIP receptors. The combined effect produces stronger appetite suppression and better metabolic outcomes for many patients.
Better tolerance for some
Some patients who experienced significant nausea on semaglutide find tirzepatide better tolerated. Individual response varies.
Transparent pricing.
- Compounded tirzepatide (all doses)
- US-licensed clinician review
- Free AI macro tracker app
- Free shipping
- 24-hour intake review
- Earn up to 30% off with consistency
Common questions about tirzepatide
- What is compounded tirzepatide?
- Compounded tirzepatide is a pharmacy-prepared version of the active ingredient in Mounjaro and Zepbound, made in a 503A-certified compounding pharmacy. It is not an FDA-approved finished drug product, but it uses the same active molecule at a fraction of the brand-name cost. Welling sources exclusively from LegitScript-certified 503A pharmacies.
- How does tirzepatide differ from semaglutide?
- Tirzepatide activates both GLP-1 and GIP receptors — a dual mechanism not present in semaglutide, which targets GLP-1 only. SURMOUNT clinical trials showed average body weight loss of approximately 20%, compared to roughly 15% for semaglutide in the SUSTAIN and STEP trials. Individual response varies significantly; your clinician helps determine which medication is the better fit based on your medical history, goals, and tolerance.
- What does compounded tirzepatide cost through Welling?
- Compounded tirzepatide starts at $275 per month for a standard starting dose. Patients who maintain consistent monthly refills qualify for the streak discount program, which can reduce the monthly cost to as low as $192 at full streak. Clinician access and the Welling coaching app are included in the Welling membership, which is billed separately from the medication.
- Is tirzepatide right for me?
- Tirzepatide is typically considered for adults with a BMI of 30 or above, or 27 or above with a weight-related health condition such as type 2 diabetes, hypertension, or sleep apnea. A US-licensed Welling clinician reviews your intake form and medical history before any prescription is written. Approval is based on clinical appropriateness and is not guaranteed.
- What side effects should I expect?
- The most commonly reported side effects of tirzepatide are gastrointestinal: nausea, vomiting, diarrhea, and constipation, particularly during the early titration phase when doses are being increased. Most patients find these symptoms improve as the body adjusts over several weeks. Your Welling clinician provides dose titration guidance designed to minimize discomfort and will adjust your schedule if side effects are significant.